Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose with or without erythropoietin for correction of preoperative anaemia in orthopaedic surgery
2009-015799-92Phase 4Completed
- Sponsor
- University Hospital Zurich Institute of Anesthesiology
- Start
- Oct 2009
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose and epoetin beta in anaemia and None (3 arms), sponsored by University Hospital Zurich Institute of Anesthesiology. Primary endpoint: Haemoglobin increase from baseline to day of surgery. Started Oct 2009; status: completed.
02
Drugs
ferric carboxymaltoseepoetin beta
03
Conditions
anaemia
Beyond the preview
Go deeper on 2009-015799-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015799-92.